News about Mercado Libre

Gordon Reid of Goodreid Investment Counsel highlights Eli Lilly, Mercado Libre and Texas Instruments as his U.S. equity picks. He says headline indexes sit near record highs, but the rally is narrow: 59% of stocks trade more than 20% below their all-time highs and 26% more than 40% below. He argues corporate earnings are strong, with year-over-year growth of 25% or more expected in the final quarter of 2026 and profit margins near 15%, while consumers are squeezed by inflation, the Iran war, tariffs and high Fed rates. The picks rest on Eli Lilly's GLP-1 opportunity, with a total addressable market estimated above US$100 billion, Mercado Libre's position as a Latin American e-commerce leader, and Texas Instruments' more stable analog chip business. Picks from October 21, 2025 show Elevance Health gaining 22% (24% total return), Rocket Companies falling 34%, and an average total return of -0.3%.